Kidney Transplantation Outcome in Patients With Augmented Bladder: A Single-Center Experience
Transplantation Proceedings · 2026-05 · 58 (4) · 690-694
DOI: 10.1016/j.transproceed.2026.03.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026-05. Verfasst von Rahmi Gokhan Ekin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Kidney Transplantation, Acibadem Healthcare Group, Kent Hospital, Izmir, Türkiye. Electronic address: gokhanekin@gmail.com. Hauptthemen laut MEDLINE: Kidney Transplantation, Urinary Bladder. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology and Kidney Transplantation, Acibadem Healthcare Group, Kent Hospital, Izmir, Türkiye. Electronic address: gokhanekin@gmail.com.
- Department of Urology, Baskent University, Izmir Hospital, Izmir, Türkiye.
- Department of Nephrology and Kidney Transplantation, Acibadem Healthcare Group, Kent Hospital, Izmir, Türkiye.
- Department of Urology and Kidney Transplantation, Acibadem Healthcare Group, Kent Hospital, Izmir, Türkiye.
Zitieren
APA
Ekin, R. G., Eroglu, A., Ok, E. S., Toz, H., & Ozgu, I. (2026). Kidney Transplantation Outcome in Patients With Augmented Bladder: A Single-Center Experience. Transplantation Proceedings, 58(4), 690-694. https://doi.org/10.1016/j.transproceed.2026.03.025
Vancouver
Ekin RG, Eroglu A, Ok ES, Toz H, Ozgu I. Kidney Transplantation Outcome in Patients With Augmented Bladder: A Single-Center Experience. Transplantation Proceedings. 2026;58(4):690-694. doi:10.1016/j.transproceed.2026.03.025
BibTeX
@article{Ekin2026,
author = {Ekin, Rahmi Gokhan and Eroglu, Askin and Ok, Ebru Sevinc and Toz, Huseyin and Ozgu, Isik},
title = {Kidney Transplantation Outcome in Patients With Augmented Bladder: A Single-Center Experience},
journal = {Transplantation Proceedings},
year = {2026},
volume = {58},
number = {4},
pages = {690--694},
doi = {10.1016/j.transproceed.2026.03.025}
}
EUVIMED